Citizens Jmp Boosts Sabra Healthcare REIT (NASDAQ:SBRA) Price Target to $25.00

Sabra Healthcare REIT (NASDAQ:SBRA) had its target price upped by investment analysts at Citizens Jmp from $23.00 to $25.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a “market outperform” rating on the real estate investment trust’s stock. Citizens Jmp’s target price indicates a potential upside of 13.48% from the stock’s previous close.

A number of other equities research analysts have also commented on SBRA. Cantor Fitzgerald raised their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Sabra Healthcare REIT in a research report on Wednesday. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday. Wells Fargo & Company raised their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Finally, Raymond James Financial started coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, June 17th. They issued an “underperform” rating on the stock. Eight investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $22.25.

Sabra Healthcare REIT Price Performance

Shares of SBRA stock opened at $22.03 on Wednesday. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. Sabra Healthcare REIT has a 12-month low of $17.17 and a 12-month high of $22.55. The firm has a fifty day moving average of $19.64 and a 200-day moving average of $19.82. The firm has a market capitalization of $5.56 billion, a price-to-earnings ratio of 34.97, a price-to-earnings-growth ratio of 1.63 and a beta of 0.65.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting the consensus estimate of $0.16. The business had revenue of $211.74 million for the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm’s revenue was up 20.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities research analysts forecast that Sabra Healthcare REIT will post 1.5 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Rothschild Investment LLC lifted its stake in Sabra Healthcare REIT by 164.6% in the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 889 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in shares of Sabra Healthcare REIT by 97.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 714 shares in the last quarter. Strengthening Families & Communities LLC bought a new position in shares of Sabra Healthcare REIT during the 4th quarter worth approximately $29,000. Versant Capital Management Inc raised its holdings in shares of Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after purchasing an additional 603 shares during the last quarter. Finally, Danske Bank A S acquired a new stake in shares of Sabra Healthcare REIT in the third quarter valued at approximately $30,000. 99.40% of the stock is owned by institutional investors and hedge funds.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.